These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38578049)

  • 1. An ELISA-Based Method to Measure Mucosal Antibody Responses Against SARS-CoV-2 in Human Saliva.
    Bhavsar D; Sano K; Singh G; Krammer F
    Curr Protoc; 2024 Apr; 4(4):e1024. PubMed ID: 38578049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary and serum IgA and IgG responses to SARS-CoV-2-spike protein following SARS-CoV-2 infection and after immunization with COVID-19 vaccines.
    Li D; Calderone R; Nsouli TM; Reznikov E; Bellanti JA
    Allergy Asthma Proc; 2022 Sep; 43(5):419-430. PubMed ID: 36065108
    [No Abstract]   [Full Text] [Related]  

  • 3. Saliva SARS-CoV-2 Antibody Prevalence in Children.
    Keuning MW; Grobben M; de Groen AC; Berman-de Jong EP; Bijlsma MW; Cohen S; Felderhof M; de Groof F; Molanus D; Oeij N; Rijpert M; van Eijk HWM; Koen G; van der Straten K; Oomen M; Visser R; Linty F; Steenhuis M; Vidarsson G; Rispens T; Plötz FB; van Gils MJ; Pajkrt D
    Microbiol Spectr; 2021 Oct; 9(2):e0073121. PubMed ID: 34523985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals.
    Sano K; Bhavsar D; Singh G; Floda D; Srivastava K; Gleason C; ; Carreño JM; Simon V; Krammer F
    Nat Commun; 2022 Sep; 13(1):5135. PubMed ID: 36050304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection.
    Abela IA; Schwarzmüller M; Ulyte A; Radtke T; Haile SR; Ammann P; Raineri A; Rueegg S; Epp S; Berger C; Böni J; Manrique A; Audigé A; Huber M; Schreiber PW; Scheier T; Fehr J; Weber J; Rusert P; Günthard HF; Kouyos RD; Puhan MA; Kriemler S; Trkola A; Pasin C
    mBio; 2024 Feb; 15(2):e0272223. PubMed ID: 38270455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a high-sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS-CoV-2 spike glycoprotein in serum and saliva.
    Faustini SE; Jossi SE; Perez-Toledo M; Shields AM; Allen JD; Watanabe Y; Newby ML; Cook A; Willcox CR; Salim M; Goodall M; Heaney JL; Marcial-Juarez E; Morley GL; Torlinska B; Wraith DC; Veenith TV; Harding S; Jolles S; Ponsford MJ; Plant T; Huissoon A; O'Shea MK; Willcox BE; Drayson MT; Crispin M; Cunningham AF; Richter AG
    Immunology; 2021 Sep; 164(1):135-147. PubMed ID: 33932228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of SARS-CoV-2 spike-specific IgA and IgG in nasal secretions, saliva and serum.
    Bladh O; Aguilera K; Marking U; Kihlgren M; Greilert Norin N; Smed-Sörensen A; Sällberg Chen M; Klingström J; Blom K; Russell MW; Havervall S; Thålin C; Åberg M
    Front Immunol; 2024; 15():1346749. PubMed ID: 38558811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of cross-reactive immunoglobulin A against the severe acute respiratory syndrome-coronavirus-2 spike 1 subunit in saliva.
    Tsukinoki K; Yamamoto T; Handa K; Iwamiya M; Saruta J; Ino S; Sakurai T
    PLoS One; 2021; 16(11):e0249979. PubMed ID: 34813596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
    Folegatti PM; Ewer KJ; Aley PK; Angus B; Becker S; Belij-Rammerstorfer S; Bellamy D; Bibi S; Bittaye M; Clutterbuck EA; Dold C; Faust SN; Finn A; Flaxman AL; Hallis B; Heath P; Jenkin D; Lazarus R; Makinson R; Minassian AM; Pollock KM; Ramasamy M; Robinson H; Snape M; Tarrant R; Voysey M; Green C; Douglas AD; Hill AVS; Lambe T; Gilbert SC; Pollard AJ;
    Lancet; 2020 Aug; 396(10249):467-478. PubMed ID: 32702298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination and Omicron BA.1/BA.2 Convalescence Enhance Systemic but Not Mucosal Immunity against BA.4/5.
    Diem G; Jäger M; Dichtl S; Bauer A; Lass-Flörl C; Reindl M; Wilflingseder D; Posch W
    Microbiol Spectr; 2023 Jun; 11(3):e0516322. PubMed ID: 37098903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Levels of Nasal, Salivary, and Plasma Antibody to Severe Acute Respiratory Syndrome Coronavirus 2 During Natural Infection and After Vaccination.
    Cohen JI; Dropulic L; Wang K; Gangler K; Morgan K; Liepshutz K; Krogmann T; Ali MA; Qin J; Wang J; Vogel JS; Lei Y; Suzuki-Williams LP; Spalding C; Palmore TN; Burbelo PD
    Clin Infect Dis; 2023 Apr; 76(8):1391-1399. PubMed ID: 36482505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail.
    Egorov AI; Griffin SM; Fuzawa M; Kobylanski J; Grindstaff R; Padgett W; Simmons S; Hallinger DR; Styles JN; Wickersham L; Sams E; Hudgens E; Wade TJ
    Microbiol Spectr; 2021 Oct; 9(2):e0069321. PubMed ID: 34523986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients.
    Isho B; Abe KT; Zuo M; Jamal AJ; Rathod B; Wang JH; Li Z; Chao G; Rojas OL; Bang YM; Pu A; Christie-Holmes N; Gervais C; Ceccarelli D; Samavarchi-Tehrani P; Guvenc F; Budylowski P; Li A; Paterson A; Yue FY; Marin LM; Caldwell L; Wrana JL; Colwill K; Sicheri F; Mubareka S; Gray-Owen SD; Drews SJ; Siqueira WL; Barrios-Rodiles M; Ostrowski M; Rini JM; Durocher Y; McGeer AJ; Gommerman JL; Gingras AC
    Sci Immunol; 2020 Oct; 5(52):. PubMed ID: 33033173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasensitive detection of salivary SARS-CoV-2 IgG antibodies in individuals with natural and COVID-19 vaccine-induced immunity.
    Thomas SN; Karger AB; Altawallbeh G; Nelson KM; Jacobs DR; Gorlin J; Barcelo H; Thyagarajan B
    Sci Rep; 2022 May; 12(1):8890. PubMed ID: 35614113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid increase in salivary IgA and broad recognition of spike protein following SARS-CoV-2 vaccination.
    Ota K; Sakai H; Sasaki D; Mitsumoto-Kaseida F; Sakamoto K; Kosai K; Hasegawa H; Takazono T; Izumikawa K; Mukae H; Tun MMN; Morita K; Yanagihara K
    Virus Res; 2024 Jan; 339():199294. PubMed ID: 38056502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection.
    Du L; Zhao G; Lin Y; Sui H; Chan C; Ma S; He Y; Jiang S; Wu C; Yuen KY; Jin DY; Zhou Y; Zheng BJ
    J Immunol; 2008 Jan; 180(2):948-56. PubMed ID: 18178835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Single Dose of BNT162b2 Messenger RNA Vaccine Induces Airway Immunity in Severe Acute Respiratory Syndrome Coronavirus 2 Naive and Recovered Coronavirus Disease 2019 Subjects.
    Martinuzzi E; Benzaquen J; Guerin O; Leroy S; Simon T; Ilie M; Hofman V; Allegra M; Tanga V; Michel E; Boutros J; Maniel C; Sicard A; Glaichenhaus N; Czerkinsky C; Blancou P; Hofman P; Marquette CH
    Clin Infect Dis; 2022 Dec; 75(12):2053-2059. PubMed ID: 35579991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Antibody Responses Against SARS-CoV-2 in Plasma and Saliva From Vaccinated and Infected Individuals.
    Klingler J; Lambert GS; Itri V; Liu S; Bandres JC; Enyindah-Asonye G; Liu X; Simon V; Gleason CR; Kleiner G; Chiu HP; Hung CT; Kowdle S; Amanat F; Lee B; Zolla-Pazner S; Upadhyay C; Hioe CE
    Front Immunol; 2021; 12():759688. PubMed ID: 34987505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization.
    Peterhoff D; Glück V; Vogel M; Schuster P; Schütz A; Neubert P; Albert V; Frisch S; Kiessling M; Pervan P; Werner M; Ritter N; Babl L; Deichner M; Hanses F; Lubnow M; Müller T; Lunz D; Hitzenbichler F; Audebert F; Hähnel V; Offner R; Müller M; Schmid S; Burkhardt R; Glück T; Koller M; Niller HH; Graf B; Salzberger B; Wenzel JJ; Jantsch J; Gessner A; Schmidt B; Wagner R
    Infection; 2021 Feb; 49(1):75-82. PubMed ID: 32827125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Bacteriophage-Based, Highly Efficacious, Needle- and Adjuvant-Free, Mucosal COVID-19 Vaccine.
    Zhu J; Jain S; Sha J; Batra H; Ananthaswamy N; Kilgore PB; Hendrix EK; Hosakote YM; Wu X; Olano JP; Kayode A; Galindo CL; Banga S; Drelich A; Tat V; Tseng CK; Chopra AK; Rao VB
    mBio; 2022 Aug; 13(4):e0182222. PubMed ID: 35900097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.